These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series. Chen CY; Lin TY; Wang CC; Shuai HA Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942 [TBL] [Abstract][Full Text] [Related]
27. Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels. Knegtering R; Baselmans P; Castelein S; Bosker F; Bruggeman R; van den Bosch RJ Am J Psychiatry; 2005 May; 162(5):1010-2. PubMed ID: 15863810 [TBL] [Abstract][Full Text] [Related]
28. Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents. Migliardi G; Spina E; D'Arrigo C; Gagliano A; Germanò E; Siracusano R; Diaz FJ; de Leon J Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1496-501. PubMed ID: 19706318 [TBL] [Abstract][Full Text] [Related]
29. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. Fric M; Laux G Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051 [TBL] [Abstract][Full Text] [Related]
30. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Keller R; Mongini F Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680 [TBL] [Abstract][Full Text] [Related]
31. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions. Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915 [TBL] [Abstract][Full Text] [Related]
32. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772 [TBL] [Abstract][Full Text] [Related]
33. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia. Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682 [TBL] [Abstract][Full Text] [Related]
34. Prolactin levels in young children with pervasive developmental disorders during risperidone treatment. Masi G; Cosenza A; Mucci M J Child Adolesc Psychopharmacol; 2001; 11(4):389-94. PubMed ID: 11838821 [TBL] [Abstract][Full Text] [Related]
36. Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders. Tollin SR J Endocrinol Invest; 2000 Dec; 23(11):765-70. PubMed ID: 11194712 [TBL] [Abstract][Full Text] [Related]
37. Iron deficiency in pediatric patients in long-term risperidone treatment. Calarge CA; Ziegler EE J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):101-9. PubMed ID: 23480322 [TBL] [Abstract][Full Text] [Related]
38. Prolactin levels during long-term risperidone treatment in children and adolescents. Findling RL; Kusumakar V; Daneman D; Moshang T; De Smedt G; Binder C J Clin Psychiatry; 2003 Nov; 64(11):1362-9. PubMed ID: 14658952 [TBL] [Abstract][Full Text] [Related]
39. Follow-up of a pregnancy with risperidone microspheres. Dabbert D; Heinze M Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649 [TBL] [Abstract][Full Text] [Related]
40. Amoxapine as an atypical antipsychotic: a comparative study vs risperidone. Apiquian R; Fresan A; Ulloa RE; de la Fuente-Sandoval C; Herrera-Estrella M; Vazquez A; Nicolini H; Kapur S Neuropsychopharmacology; 2005 Dec; 30(12):2236-44. PubMed ID: 15956984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]